Experience of tinnitus in adults who have severe-to-profound hearing loss: A scoping review.

assessment deafness experience priority question tinnitus

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 04 08 2022
accepted: 26 09 2022
entrez: 17 11 2022
pubmed: 18 11 2022
medline: 18 11 2022
Statut: epublish

Résumé

Tinnitus is defined as the subjective perception of sound in the absence of an external stimulus, and tinnitus disorder becomes relevant when it is associated with emotional distress, cognitive dysfunction, and/or autonomic arousal. Hearing loss is recognized as the main risk factor for the pathogenesis of tinnitus. However, clinical guidelines for tinnitus disorder provide little direction for those who have severe-to-profound hearing loss including those who are pre-lingually Deaf. The aim of this scoping review was to catalogue what is known from the existing literature regarding the experience and management of tinnitus in adults who have a severe-to-profound hearing loss. A scoping review was conducted following the Preferred Reporting Item for Systematic Reviews and Meta-analysis extension for Scoping Reviews. Records were included if they reported an evaluation of tinnitus in adults who had severe-to-profound hearing loss. The online databases Ovid (MEDLINE, EMBASE and PsycINFO), CINAHL, ProQuest, Scopus, and Google Scholar were searched using the search terms 'tinnitus' (as a MESH term) and 'deaf' OR 'profound hearing loss. Thirty-five records met the inclusion criteria for this review and were cataloged according to three major themes: Impact of tinnitus in deaf adults; Primary treatment of tinnitus in deaf adults; and Cochlear implant studies where tinnitus was a secondary outcome. Tinnitus symptom severity was assessed before and after intervention using tinnitus validated questionnaires in 29 records, with six further records using other assessment tools to measure tinnitus severity. Participants using cochlear implants were included in 30 studies. Medication, repetitive transcranial magnetic stimulation (rTMS), electrical promontory stimulation, and behavioral self-control therapy were each reported in single records. This scoping review cataloged the experience, assessment, and treatment of tinnitus in adults who have severe-to-profound hearing loss. It is shown that there is very limited research reported in this field. Although this review included many records, most focused on the provision of cochlear implants for severe-to-profound hearing loss, with assessment and measurement of tinnitus as a baseline or secondary outcome. Largely missing in the literature are empirical studies that seek firstly to understand the nature of the experience of tinnitus by people with no or little residual access to external sound.

Sections du résumé

Background UNASSIGNED
Tinnitus is defined as the subjective perception of sound in the absence of an external stimulus, and tinnitus disorder becomes relevant when it is associated with emotional distress, cognitive dysfunction, and/or autonomic arousal. Hearing loss is recognized as the main risk factor for the pathogenesis of tinnitus. However, clinical guidelines for tinnitus disorder provide little direction for those who have severe-to-profound hearing loss including those who are pre-lingually Deaf. The aim of this scoping review was to catalogue what is known from the existing literature regarding the experience and management of tinnitus in adults who have a severe-to-profound hearing loss.
Summary UNASSIGNED
A scoping review was conducted following the Preferred Reporting Item for Systematic Reviews and Meta-analysis extension for Scoping Reviews. Records were included if they reported an evaluation of tinnitus in adults who had severe-to-profound hearing loss. The online databases Ovid (MEDLINE, EMBASE and PsycINFO), CINAHL, ProQuest, Scopus, and Google Scholar were searched using the search terms 'tinnitus' (as a MESH term) and 'deaf' OR 'profound hearing loss. Thirty-five records met the inclusion criteria for this review and were cataloged according to three major themes: Impact of tinnitus in deaf adults; Primary treatment of tinnitus in deaf adults; and Cochlear implant studies where tinnitus was a secondary outcome. Tinnitus symptom severity was assessed before and after intervention using tinnitus validated questionnaires in 29 records, with six further records using other assessment tools to measure tinnitus severity. Participants using cochlear implants were included in 30 studies. Medication, repetitive transcranial magnetic stimulation (rTMS), electrical promontory stimulation, and behavioral self-control therapy were each reported in single records.
Key messages UNASSIGNED
This scoping review cataloged the experience, assessment, and treatment of tinnitus in adults who have severe-to-profound hearing loss. It is shown that there is very limited research reported in this field. Although this review included many records, most focused on the provision of cochlear implants for severe-to-profound hearing loss, with assessment and measurement of tinnitus as a baseline or secondary outcome. Largely missing in the literature are empirical studies that seek firstly to understand the nature of the experience of tinnitus by people with no or little residual access to external sound.

Identifiants

pubmed: 36388182
doi: 10.3389/fneur.2022.1004059
pmc: PMC9650103
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

1004059

Informations de copyright

Copyright © 2022 Alzahrani, Sereda, Chamouton, Haider, Dewey and Hoare.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Int Med Res. 2021 Mar;49(3):300060521999549
pubmed: 33729855
ORL J Otorhinolaryngol Relat Spec. 2020;82(4):209-215
pubmed: 32594084
Physiol Rev. 2021 Oct 1;101(4):1609-1632
pubmed: 33769102
Ear Hear. 2020 Jun 16;42(1):235-243
pubmed: 32568801
Int Tinnitus J. 2009;15(1):100-6
pubmed: 19842353
Brain Stimul. 2021 Jan-Feb;14(1):113-128
pubmed: 33276156
Int Tinnitus J. 2018 Jun 01;22(1):77-83
pubmed: 29993222
Audiol Neurootol. 2012;17(1):2-11
pubmed: 21540584
Biopsychosoc Med. 2018 Nov 26;12:17
pubmed: 30534194
Ear Hear. 2012 Mar-Apr;33(2):153-76
pubmed: 22156949
Ear Hear. 1990 Dec;11(6):434-45
pubmed: 2073977
HNO. 1994 Mar;42(3):166-72
pubmed: 8175381
HNO. 2019 Mar;67(Suppl 1):10-42
pubmed: 30847513
Am J Audiol. 2009 Dec;18(2):144-51
pubmed: 19949236
Laryngoscope. 1994 Jun;104(6 Pt 1):752-4
pubmed: 8196452
Acta Otorrinolaringol Esp. 2010 Nov-Dec;61(6):405-11
pubmed: 20880513
Acta Otolaryngol. 2015 Aug;135(8):781-5
pubmed: 25812721
Ann Otol Rhinol Laryngol Suppl. 1995 Apr;165:25-30
pubmed: 7717631
Laryngoscope. 2012 Jan;122(1):196-203
pubmed: 21997855
Otol Neurotol. 2020 Feb;41(2):153-166
pubmed: 31743297
Ann Otol Rhinol Laryngol. 2016 Apr;125(4):303-10
pubmed: 26481177
Otol Neurotol. 2020 Jun;41(5):e563-e574
pubmed: 32068692
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Eur Arch Otorhinolaryngol. 2013 May;270(6):1803-8
pubmed: 23053375
Lancet. 2015 Nov 28;386(10009):2140-1
pubmed: 26638958
Laryngoscope. 2016 Apr;126(4):956-61
pubmed: 26255618
Acta Otolaryngol. 2008 Feb;128(2):159-63
pubmed: 17851950
Arch Otolaryngol Head Neck Surg. 1996 Feb;122(2):143-8
pubmed: 8630207
Int J Audiol. 2015 Jul;55(7):392-404
pubmed: 27146518
Front Aging Neurosci. 2017 Jun 16;9:192
pubmed: 28670275
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Lancet Neurol. 2013 Sep;12(9):920-930
pubmed: 23948178
Laryngoscope. 2011 Oct;121(10):2220-7
pubmed: 21898434
Arch Otolaryngol Head Neck Surg. 1992 Dec;118(12):1291-7
pubmed: 1449687
Am J Audiol. 2015 Mar;24(1):66-77
pubmed: 25551458
Front Neurol. 2017 Apr 25;8:158
pubmed: 28487670
Cochrane Database Syst Rev. 2020 Jan 8;1:CD012614
pubmed: 31912887
Int Tinnitus J. 1997;3(1):35-38
pubmed: 10753361
Int J Audiol. 2004 Nov-Dec;43(10):600-4
pubmed: 15724525
BMJ Open. 2018 Jun 11;8(6):e021068
pubmed: 29895652
Int Tinnitus J. 1998;4(2):159-161
pubmed: 10753407
Laryngoscope. 2016 Dec;126(12):2811-2816
pubmed: 27075602
J Int Adv Otol. 2022 May;18(3):196-202
pubmed: 35608486
Prog Brain Res. 2021;260:1-25
pubmed: 33637213
Trials. 2021 Dec 04;22(1):875
pubmed: 34863270
Otolaryngol Head Neck Surg. 2021 Apr;164(4):859-868
pubmed: 32988263
Ear Hear. 2016 Nov/Dec;37(6):e402-e408
pubmed: 27438865
Lancet. 2019 Feb 2;393(10170):404-405
pubmed: 30722956
Otol Neurotol. 2001 Mar;22(2):200-4
pubmed: 11300269
Otol Neurotol. 2012 Sep;33(7):1169-75
pubmed: 22892805
Int J Audiol. 2022 Apr;61(4):322-328
pubmed: 34278941
Semin Hear. 2018 Nov;39(4):390-404
pubmed: 30374210
Audiol Neurootol. 2016;21(3):165-71
pubmed: 27161899
Otol Neurotol. 2020 Feb;41(2):196-201
pubmed: 31834209
Am J Otolaryngol. 1994 Mar-Apr;15(2):145-8
pubmed: 8179106
Eur Arch Otorhinolaryngol. 2007 Oct;264(10):1145-9
pubmed: 17558507

Auteurs

Lama Alzahrani (L)

NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Audiology Clinic, Otolaryngology Department, King Abdul-Aziz University Hospital, Jeddah, Saudi Arabia.

Magdalena Sereda (M)

NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Carla Salles Chamouton (CS)

UNICAMP University of Campinas, Campinas, Brazil.

Háula Haider (H)

ENT Department, Hospital Cuf Tejo-Nova Medical School, Lisbon, Portugal.

Rebecca Susan Dewey (RS)

NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom.

Derek J Hoare (DJ)

NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Classifications MeSH